Balchem Corporation
BCPCBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Oct 24, 2026
Scan Results
Daily timeframeBalchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization,. Valued at $5.64B, BCPC is a mid-cap name in its sector. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Market Cap
$5.64B
Beta
0.85
P/E (TTM)
34.84
P/E (Fwd)
28.22
EPS (TTM)
$5.08
EPS (Fwd)
$6.27
ROE
12.8%
ROA
8.2%
Cash
$63.2M
Total Debt
$166.7M
Free CF
$134.8M
52W Change
13.0%
Annual Financials
Cash vs Debt
Where BCPC stands vs its 150-day and 200-day moving averages
As of the October 14, 2026 close, BCPC finished 1.03% above its 150-day moving average ($167.99) and 0.80% above its 200-day moving average ($168.37). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BCPC overbought or oversold?
At the October 14, 2026 close, BCPC's RSI(14) was 54.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Balchem Corporation carries $166.7M in total debt against $63.2M in cash reserves — debt is roughly 2.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $134.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 12.8% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $942.4M to $1.04B.
As with any equity investment, BCPC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Balchem Corporation and its sector.